Avid Bioservices to Participate in 18th Annual Morgan Stanley Global Healthcare Conference
September 10 2020 - 8:05AM
Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a
dedicated biologics contract development and manufacturing
organization (CDMO) working to improve patient lives by providing
high quality development and manufacturing services to
biotechnology and pharmaceutical companies, today announced that
the company will participate in the 18th Annual Morgan Stanley
Global Healthcare Conference. The conference, which will take
place September 14-18, 2020, is being conducted with a virtual
format.
Details of the company’s participation are as follows:
- 18th Annual Morgan Stanley Global Healthcare
ConferenceDetails: Avid management will participate in a
fireside chat and 1-on-1 meetingsConference Date: September 14-18,
2020 Fireside Chat Time/Date: 4:15 p.m. Eastern on Thursday,
September 17, 2020Format: Virtual Conference
A webcast of the fireside chat will be made available. To
listen to the live webcast, or access the archived webcast, please
visit: http://ir.avidbio.com/investor-events.
About Avid
Bioservices, Inc.
Avid Bioservices is a dedicated contract
development and manufacturing organization (CDMO) focused on
development and CGMP manufacturing of biopharmaceutical drug
substances derived from mammalian cell culture. The company
provides a comprehensive range of process development, CGMP
clinical and commercial manufacturing services for the
biotechnology and biopharmaceutical industries. With 27 years of
experience producing monoclonal antibodies and recombinant
proteins, Avid's services include CGMP clinical and commercial drug
substance manufacturing, bulk packaging, release and stability
testing and regulatory submissions support. For early-stage
programs the company provides a variety of process development
activities, including upstream and downstream development and
optimization, analytical methods development, testing and
characterization. The scope of our services ranges from
standalone process development projects to full development and
manufacturing programs through commercialization.
www.avidbio.com.
Contacts:
Stephanie Diaz (Investors)
Vida Strategic Partners
415-675-7401
sdiaz@vidasp.com
Tim Brons (Media)
Vida Strategic Partners
415-675-7402
tbrons@vidasp.com
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Apr 2023 to Apr 2024